BIOLASE

BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems use a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The Diode systems perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company was founded in 1987 and is headquartered in Lake Forest, CA.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

BIOLASE reports strong Q1 performance, eyes profitability through market growth

BIOLASE's Q1 2024 earnings reflect a robust performance with growth in sales and improved financial metrics. The company's strategic focus on accelerating dental laser adoption and operational enhancements position it well for future success. While challenges exist in achieving profitability, BIOLASE's opportunities in the dental market and growth initiatives offer a positive outlook.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems use a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The Diode systems perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company was founded in 1984 and is headquartered in Lake Forest, CA.

IRVINE, Calif., May 6, 2021 /PRNewswire/ --  BIOLASE, Inc.  (NASDAQ: BIOL), the global leader in dental lasers, announced today its Waterlase Pediatric Dental Academy (WPDA), for Waterlase pediatric dentists.

BIOLASE Announces the Launch of Waterlase Pediatric Dental Academy

FOOTHILL RANCH, Calif., May 3, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today sent the following letter to stockholders regarding the upcoming 2021 annual meeting of stockholders scheduled to be held on May 26, 2021.

BIOLASE Urges Stockholders To Vote "FOR" ALL Proposals At Upcoming Annual Meeting

Drive Shack

Muscle Maker

Hot penny stocks to watch during reopening? Check these 3 out The post Reopening Penny Stocks to Buy?

Reopening Penny Stocks to Buy? 3 to Watch in May 2021

Ault Global Holdings

VistaGen Therapeutics

Penny stock watchlists? Why they're not as complicated as they seem The post Penny Stocks Watchlists and How to Make One appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Penny Stocks Watchlists and How to Make One

Aikido Pharma Inc.

Brickell Biotech Inc

Biotech stocks are more popular than ever; here are 3 to watch under $5 The post Biotech Penny Stocks To Buy? 3 to Watch Under $5 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Biotech Penny Stocks To Buy? 3 to Watch Under $5

AzurRx BioPharma

Wrap Technologies

Reopening penny stocks that investors are watching right now The post 3 Reopening Penny Stocks to Watch in April 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Reopening Penny Stocks to Watch in April 2021

BIOLASE Inc (NASDAQ: BIOL) and EdgeEndo have announced the co-development of EdgePRO, a next-generation Laser-Assisted Microfluidic Irrigation device for endodontists. This new Microfluidic Irrigation device is being developed to offer a solution for endodontists, seeking more from their current cleaning and disinfection techniques, such as sodium hypochlorite, ethylenediaminetetraacetic acid, chlorhexidine, or 2-in-1 or 3-in-1 irrigation solutions.

BIOLASE, EdgeEndo Team Up To Develop New Microfluidic Irrigation Device For Endodontists

FOOTHILL RANCH, Calif., April 20, 2021 /PRNewswire/ --  BIOLASE, Inc.  (NASDAQ: BIOL), the global leader in dental lasers, and  EdgeEndo , a global leader in commercializing endodontic products, announced in association with the American Association of Endodontists (AAE) Annual Meeting beginning on April 21, 2021, the co-development of EdgePRO, a next-generation Laser-Assisted Microfluidic Irrigation device for endodontists.

BIOLASE and EdgeEndo Announce Plans to Develop New EdgePRO Laser-Assisted Microfluidic Irrigation Device for Endodontists

Dental tech player Biolase has been making moves that have attracted investors, and today BIOL stock is seeing the payoff. The post BIOL Stock: 9 Things to Know As Red-Hot Biolase Rockets Higher appeared first on InvestorPlace.

BIOL Stock: 9 Things to Know As Red-Hot Biolase Rockets Higher

FOOTHILL RANCH, Calif., March 30, 2021 /PRNewswire/ --  BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced a pilot program with Einstein Healthcare Network's residency in endodontics to train endodontic residents in the use of Waterlase dental lasers.

BIOLASE Announces Collaboration with Einstein Healthcare Network's Residency in Endodontics

BIOLASE, Inc. (BIOL) CEO John Beaver on Q4 2020 Results - Earnings Call Transcript

FOOTHILL RANCH, Calif., March 25, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the fourth quarter and full year ended December 31, 2020.

BIOLASE Reports 31% Sequential Revenue Growth In 2020 Fourth Quarter; Demand From New Users Driving Positive Performance

FOOTHILL RANCH, Calif., March 17, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release fourth quarter and full-year 2020 financial and operating results on Thursday, March 25, 2021, after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m.

BIOLASE, Inc. to Report Fourth Quarter and Full Year 2020 Results on March 25, 2021

FOOTHILL RANCH, Calif., March 16, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that John Beaver, President and Chief Executive Officer, is scheduled to present at Maxim Group's Inaugural 2021 Emerging Growth Virtual Investor Conference to be held March 17-19, 2021.

BIOLASE To Participate In Maxim Group's Inaugural 2021 Emerging Growth Virtual Investor Conference

FOOTHILL RANCH, Calif., Feb. 24, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that John Beaver, President and Chief Executive Officer, will be providing an overview of the Company, as well as recent progress and achievements at the...

BIOLASE To Participate In H.C. Wainwright Investor Conference

FOOTHILL RANCH, Calif., Feb. 23, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today announced that the Board of Directors has appointed John R. Beaver, the Company's current Executive Vice President, Chief Operating Officer and Chief Financial...

John R. Beaver Promoted To President And Chief Executive Officer Of BIOLASE; Will Leverage Dental Knowledge And Management Expertise To Achieve Growth Objectives

BIOLASE Inc (NASDAQ: BIOL) has announced to sell 14 million common shares at $1.03 per share, raising $14.4 million in gross proceeds. The offering price represents a discount of 15% from the last close price of $1.21.

BIOLASE Raises $14.4M From Maxim Group At 15% Discount

IRVINE, Calif., Feb. 5, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has entered into an underwriting agreement with Maxim Group LLC under which the underwriters have agreed to purchase, on a firm commitment basis,...

BIOLASE, Inc. Announces Pricing of $14.4 Million Bought Deal Offering

FOOTHILL RANCH, Calif., Feb. 4, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today received official notification from the Listing Qualifications Department of the Nasdaq Stock Market Inc. ("NASDAQ") that it has regained compliance with the minimum...

BIOLASE Regains Compliance With Nasdaq Minimum Bid Price Requirement And Cancels Special Meeting Of Stockholders

FOOTHILL RANCH, Calif., Feb. 1, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, encourages stockholders to vote their shares with respect to the adjourned special meeting of stockholders initially held on January 22, 2021 (the "Special Meeting"),...

BIOLASE Urges Stockholders To Vote Today "FOR" The Reverse Stock Split

Marathon Oil

Westport Fuel Systems

Akerna Corp

Organogenesis Holdings

While most of Wall Street focuses on large- and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy.

5 Red-Hot Stocks Trading Under $10 With Massive Upside Potential

The stock price of BIOLASE Inc (NASDAQ: BIOL) is trading down over 5% today. This is why it happened.

BIOL Stock Price Falls Over 5%: Why It Happened

The stock price of BIOLASE Inc (NASDAQ: BIOL) has increased by 80.09% as it went from a previous close of $0.58 to $1.04. This is why it happened.

BIOL Stock Price Increased 80.09%: Why It Happened

Biolase (BIOL) stock is flying high on Tuesday after announcing a massive deal for its dental lasers with Dental Care Alliance. The post BIOL Stock Alert: 14 Things for Potential Investors to Know About Biolase appeared first on InvestorPlace.

BIOL Stock Alert: 14 Things for Potential Investors to Know About Biolase

Jaguar Health

Senseonics Holdings

Tonix Pharmaceuticals Hld

This article is going to explain what penny stocks are and discuss four penny stocks under $1 to watch as small-cap stocks continue a hot streak this winter. First thing's first, what are penny stocks?

News for BIOLASE Stock (BIOL)